Intuitive Surgical Inc. (ISRG) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the syst...
Intuitive Surgical Inc.'s revenue increased 20.5% year over year, from $8.35B to $10.06B.
Net income increased 23.0% over the same period, from $2.32B to $2.86B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 272% in total.
Operating cash flow grew 25.5% to $3.03B.
Intuitive Surgical Inc. maintains a strong net profit margin of 28.4%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Equity |
|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $2.04B+1.4% | $565.1M | $1.37B | $577.3M | $706.5M | $17.74B | $15.58B |
| Q4 FY2024 | $2.41B+18.4% | $685.7M | $1.64B | $734.9M | $822.6M | $18.74B | $16.43B |
| Q1 FY2025 | $2.25B-6.6% | $698.4M | $1.46B | $578.1M | $581.6M | $19.22B | $17.11B |
| Q2 FY2025 | $2.44B+8.3% | $658.4M | $1.62B | $743.4M | $715.4M | $20.16B | $17.85B |
| Q3 FY2025 | $2.51B+2.7% | $704.4M | $1.66B | $759.7M | $841.0M | $19.35B | $16.93B |
| Q4 FY2025 | $2.87B+14.4% | $794.8M | $1.90B | $864.3M | $892.5M | $20.46B | $17.82B |
| Q1 FY2026 | $2.77B-3.3% | $821.5M | $1.83B | $855.3M | $911.9M | N/A | N/A |
| Q2 FY2026 | $2.89B+4.4% | $818.1M | $1.96B | $971.9M | $1.06B | N/A | N/A |
Balance Sheet Summary (FY2025)
Intuitive Surgical Inc. (ISRG) Financial Statements & Revenue History
Intuitive Surgical Inc. (ISRG) is a US-listed stock operating in the Healthcare sector, specifically the Medical Devices industry trading at $423.00 with a market capitalization of $149. This page provides 42 historical financial statements for Intuitive Surgical Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Intuitive Surgical Inc. reported revenue of $10.1 billion, representing 20.5% year-over-year growth. The net profit margin of 28.4% reflects strong profitability..
ISRG Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Intuitive Surgical Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether ISRG is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track ISRG's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Intuitive Surgical Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of ISRG's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use ISRG Financial Data
Investors use Intuitive Surgical Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare ISRG's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how ISRG's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View ISRG's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Intuitive Surgical Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.ISRG trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.